Skip to content

Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their Sexuality

Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their Sexuality

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03572621
Acronym
PRODUCAN
Enrollment
240
Registered
2018-06-28
Start date
2020-02-03
Completion date
2024-09-30
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostatectomy

Brief summary

Prostate cancer is the most common cancer in France (54,000 cases in 2011). About 20,000 radical prostatectomies (PR) per year are performed. Despite the progress of PR over the past 20 years, the rate of erectile dysfunction post PR varies between 30 and 90% and only 16% of operated men recover their pre-treatment erections. There is currently no validated post-prostatectomy rehabilitation protocol. The associations of patients, including the National Association of Prostate Cancer Patients have a very strong demand for treatment of sexual problems after treatment.

Interventions

OTHERTherapeutic education

Patients will benefit from the first session of preoperative therapeutic education, then the next 5 sessions will be done postoperatively over a period of 4 month and a half. Session 1: The first session will be devoted appropriately to patient education. It will take place on the day of the preoperative anesthesia consultation. Session 2: day of discharge from hospital. Make the patient adhere to the concept of post PR erectile rehabilitation in the same way as sphincter reeducation. Session 3: Presentation of available treatments, start intracavernous injections. Session 4: Acquisition of know-how on treatment management. Reduce anxiety. Session 5: Encourage the resumption of intercourse very gradually. The presence of the partner will be advised. Session 6: measure of the evolution of the representations and knowledge of the patient. The skills of the patient will be evaluated from problem situations, motivation scale. The know-how will be evaluated using observation grid.

OTHERCollection of data concerning their sexuality

Patients in the control group are offered to participate in the study, which consists of collecting data on their sexuality. This in addition to the current care by the teams of care about erectile rehabilitation (information and medication prescriptions).

OTHERParticipation

Participation in a therapeutic education day.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients treated in urology consultation at the University Hospital of Lyon Sud or Edouard Herriot: * Aged over 18 * presenting a cancerous pathology of the prostate having an indication of radical prostatectomy with or without preservation of the neurovascular strips. * affiliated to a social security scheme. * and having been informed and given informed consent to participation in the program.

Exclusion criteria

* Refusal of participation, signature of consent, * protected major patients, under guardianship or curators. * Patients unable to understand the course of the study * Patient with a documented history of cognitive or psychiatric disorders.

Design outcomes

Primary

MeasureTime frameDescription
Change the quality of sexual life of patients treated with radical prostatectomy (PR)18 monthsComparison of the difference in self-Esteem quotation and Relationship (SEAR) questionnaire, between the experimental group and control, between inclusion and Month 18.

Secondary

MeasureTime frameDescription
General quality of lifeMonth 1, 6, 12 and 18Signing of questionnaire EuroQol-D5 (EQ-D5)
Sexual quality of life of the partnerMonth 1, 6, 12 and 18Index of Sexual Life (ISL) questionnaire, validated questionnaire specifically created to assess the impact of erectile dysfunction (ED) in the partner.
Number of erections obtained in the last monthMonth 1, 6, 12 and 18Patient questionnaire to be filled every month at home by the patient and the partner
Number of reports deemed satisfactoryMonth 1, 6, 12 and 18Patient questionnaire to be filled every month at home by the patient and the partner
Number of intracavernous injections performed per weekMonth18Patient questionnaire to be filled every month at home by the patient and the partner
Patient Activation Measure (questionnaire PAM)Month18
Sexual functionMonth 1, 6, 12 and 18Measure of The International Index of Erectile Function (IIEF-EF) score. This validated score measures the erectile component.
Continence: urinary handicap measurement scale (MHU)Month 1, 6, 12 and 18
Penis size (cm)Month 1, 6, 12 and 18
Knowledge acquisition measured by quizz build for the study made of simulated casesMonth 1, 6, 12 and 18
acquisition of sexual intercourse management skills measured by quizz build for the study made of simulated casesMonth 1, 6, 12 and 18
Anxiety level measured by the Hospital Anxiety and Depression (HAD) scaleMonth 6 and18
Depression level measured by the Hospital Anxiety and Depression (HAD) scaleMonth 6 and18
Erection Hardness Score (EHS)Month 1, 6, 12 and 18

Countries

France

Contacts

Primary ContactDamien CARNICELLI, MD
damien.carnicelli@chu-lyon.fr04 72 67 88 01

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026